Skip Navigation


NDT Advance Access originally published online on January 8, 2007
Nephrology Dialysis Transplantation 2007 22(3):906-910; doi:10.1093/ndt/gfl714
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/3/906    most recent
gfl714v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Keven, K.
Right arrow Articles by Erbay, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keven, K.
Right arrow Articles by Erbay, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Renal tubular acidosis after kidney transplantation—incidence, risk factors and clinical implications

Kenan Keven, Ramazan Ozturk, Sule Sengul, Sim Kutlay, Ihsan Ergun, Sehsuvar Erturk and Bulent Erbay

Department of Nephrology, Ankara University School of Medicine, Ankara, Turkey

Correspondence and offprint requests to: Kenan Keven, Department of Nephrology, Ankara University School of Medicine, Ibni Sina Hospital, Ankara 06100, Turkey. Email: keven{at}medicine.ankara.edu.tr



  Abstract

Background. Renal tubular acidosis (RTA) is a non-anion gap metabolic acidosis and is generally mild and asymptomatic in kidney recipients. Although calcineurin inhibitors, suboptimal allograft function, donor age and acute rejection have been associated with RTA, no detailed study has been conducted to investigate the prevalence and clinical implications of RTA in long-term kidney recipients.

Methods. In this cross-sectional study, we enrolled 109 patients (74 males, 35 females) for the study [patients with glomerular filtration rate (GFR) <30 ml/min/1.73 m2, unstable allograft function, diarrhoea, and respiratory disease were excluded]. Thirty-six patients (33%) were found to have RTA on the basis of plasma bicarbonate, arterial pH, urine and serum anion gap measurements.

Results. Deceased donor transplantation [P = 0.034, 95% confidence interval (CI): 1.10–13.27], female gender (P = 0.017, 95% CI: 1.23–8.50), and lower GFR (55.8 ± 19.4 in RTA and 66.1 ± 15.9 ml/min/1.73 m2 in non-RTA, P = 0.002, 95% CI: 1.10–13.27) were independent risk factors for RTA. Also, C-reactive protein was found to be higher in the RTA group (2.7 ± 1.5 vs 2.0 ± 1.5 mg/dl, P = 0.03), while no difference was noticed in body mass index or serum albumin. Analysis of the prevalence of osteoporosis and osteopenia in patients with RTA and without RTA, respectively, revealed no difference in frequency of osteoporosis (33% vs 31%) or osteopenia (33% vs 47%).

Conclusion. Although long-term kidney recipients have a relatively high prevalence of RTA, it is usually mild and subclinical. Further studies are needed to clarify long-term effects of RTA in kidney recipients.

Keywords: kidney; osteoporosis; renal tubular acidosis; transplantation

Received for publication: 29. 6.06
Accepted in revised form: 3.11.06


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.